Investor-rights law firm Rosen said it is preparing a securities class action after short seller Pelican Way Research alleged Blaize’s recent $50 million NeoTensr deal was fraudulent.
Rosen Law Firm said it is investigating potential securities claims on behalf of Blaize Holdings shareholders over allegations that the company may have issued materially misleading business information to investors. The inquiry centers on an April 28, 2026 report by short seller Pelican Way Research alleging that Blaize’s recent $50 million deal with NeoTensr was fraudulent. Blaize shares fell 12% on April 28, 2026 following the report, according to an Investing.com article cited by Rosen. The firm said it is preparing a class action and that purchasers of Blaize securities may be entitled to compensation through a contingency fee arrangement.